Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Schroeder

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Probes|May 17, 2015
Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathiesStephan Waldmüller, Christopher Schroeder, Marc Sturm, et al.
Molecular Genetics & Genomic Medicine|February 10, 2023
Genome sequencing identifies complex structural MLH1 variant in unsolved Lynch syndromeDennis Witt, Ulrike Faust, Gertrud Strobl-Wildemann, et al.
Pigment Cell & Melanoma Research|June 4, 2026
Copy Number Analysis in Congenital Nevi: Concordance and Diagnostic Limitations of aCGH, sWGS, and Methylation SequencingAnton Karelin, Ines B Brecht, Michaela Pogoda, et al.
Cancers|August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma PatientsFranz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.
European Journal of Human Genetics : EJHG|May 8, 2014
Genome-wide UPD screening in patients with intellectual disabilityChristopher Schroeder, Arif Bülent Ekici, Ute Moog, et al.
Frontiers in Oncology|April 22, 2025
Case Report: FGFR2 inhibitor resistance via <i>PIK3CA</i> and <i>CDKN2A/B</i> in an intrahepatic cholangiocarcinoma patient with <i>FGFR2-SH3GLB1</i> fusionNadja Ballin, Alexander Ott, Olga Seibel-Kelemen, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapyJulia Eckardt, Christopher Schroeder, Peter Martus, et al.
Biology|December 30, 2025
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and SurvivalAxel Gschwind, Nadja Ballin, Alexander Ott, et al.
Cell Death & Disease|May 17, 2023
ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways-lessons from breast cancer patientsJuliane Sachsenweger, Rebecca Jansche, Tatjana Merk, et al.
NPJ Genomic Medicine|March 15, 2024
Genomes in clinical careOlaf Riess, Marc Sturm, Benita Menden, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Probes|May 17, 2015
Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathiesStephan Waldmüller, Christopher Schroeder, Marc Sturm, et al.
Molecular Genetics & Genomic Medicine|February 10, 2023
Genome sequencing identifies complex structural MLH1 variant in unsolved Lynch syndromeDennis Witt, Ulrike Faust, Gertrud Strobl-Wildemann, et al.
Pigment Cell & Melanoma Research|June 4, 2026
Copy Number Analysis in Congenital Nevi: Concordance and Diagnostic Limitations of aCGH, sWGS, and Methylation SequencingAnton Karelin, Ines B Brecht, Michaela Pogoda, et al.
Cancers|August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma PatientsFranz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.
European Journal of Human Genetics : EJHG|May 8, 2014
Genome-wide UPD screening in patients with intellectual disabilityChristopher Schroeder, Arif Bülent Ekici, Ute Moog, et al.
Frontiers in Oncology|April 22, 2025
Case Report: FGFR2 inhibitor resistance via <i>PIK3CA</i> and <i>CDKN2A/B</i> in an intrahepatic cholangiocarcinoma patient with <i>FGFR2-SH3GLB1</i> fusionNadja Ballin, Alexander Ott, Olga Seibel-Kelemen, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapyJulia Eckardt, Christopher Schroeder, Peter Martus, et al.
Biology|December 30, 2025
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and SurvivalAxel Gschwind, Nadja Ballin, Alexander Ott, et al.
Cell Death & Disease|May 17, 2023
ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways-lessons from breast cancer patientsJuliane Sachsenweger, Rebecca Jansche, Tatjana Merk, et al.
NPJ Genomic Medicine|March 15, 2024
Genomes in clinical careOlaf Riess, Marc Sturm, Benita Menden, et al.
Pageof 8